Literature DB >> 9817129

Deriving a preference-based single index from the UK SF-36 Health Survey.

J Brazier1, T Usherwood, R Harper, K Thomas.   

Abstract

This article presents the results of a study to derive a preference-based single index from the SF-36. The study was an attempt to reconcile a profile health status measure, the SF-36, with the "quality adjusted life years" approach. The study undertook a parsimonious restructuring of the SF-36 using explicit criteria to form the SF-6D health state classification. A sample of multidimensional health states defined by this classification were valued by a convenience sample of health professionals, managers, and patients, who responded to a set of visual analogue scale ratings and standard gamble questions, with highly complete and consistent answers. Statistical models were estimated to predict single index scores for all 9000 health states defined by the new classification. The resultant algorithms can be applied to existing SF-36 data sets and used in the assessment of the cost-effectiveness of health technologies. This preliminary work forms the basis of a larger study currently being undertaken in the UK.

Entities:  

Mesh:

Year:  1998        PMID: 9817129     DOI: 10.1016/s0895-4356(98)00103-6

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  190 in total

Review 1.  Utility scores for different health states related to depression: individual participant data analysis.

Authors:  Spyros Kolovos; Judith E Bosmans; Johanna M van Dongen; Birre van Esveld; Dorcas Magai; Annemieke van Straten; Christina van der Feltz-Cornelis; Kirsten M van Steenbergen-Weijenburg; Klaas M Huijbregts; Harm van Marwijk; Heleen Riper; Maurits W van Tulder
Journal:  Qual Life Res       Date:  2017-03-04       Impact factor: 4.147

Review 2.  The development and use of quality-of-life measures to evaluate health outcomes in Japan.

Authors:  Shunichi Fukuhara; Naoki Ikegami; George W Torrance; Shuzo Nishimura; Michael Drummond; François Schubert
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients.

Authors:  Francis S Lobo; Cynthia R Gross; Barbara J Matthees
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

4.  Quantitative assessment of changes in patients' constructs of quality of life: an application of multilevel models.

Authors:  Adam Lowy; Jürg Bernhard
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

Review 5.  Use of patient-reported outcomes in the context of different levels of data.

Authors:  Ola Rolfson; Alastair Rothwell; Art Sedrakyan; Kate Eresian Chenok; Eric Bohm; Kevin J Bozic; Göran Garellick
Journal:  J Bone Joint Surg Am       Date:  2011-12-21       Impact factor: 5.284

Review 6.  Evaluation of content on EQ-5D as compared to disease-specific utility measures.

Authors:  Fang-Ju Lin; Louise Longworth; A Simon Pickard
Journal:  Qual Life Res       Date:  2012-06-23       Impact factor: 4.147

7.  Developing preference-based health measures: using Rasch analysis to generate health state values.

Authors:  Tracey A Young; Donna Rowen; Josephine Norquist; John E Brazier
Journal:  Qual Life Res       Date:  2010-05-08       Impact factor: 4.147

8.  The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.

Authors:  Y Yazdanpanah; M Vray; J Meynard; E Losina; M C Weinstein; L Morand-Joubert; S J Goldie; H E Hsu; R P Walensky; C Dalban; P E Sax; P M Girard; K A Freedberg
Journal:  HIV Med       Date:  2007-10       Impact factor: 3.180

9.  Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis.

Authors:  Samuel Herzog; Marian Shanahan; Peter Grimison; Anh Tran; Nicole Wong; Nicholas Lintzeris; John Simes; Martin Stockler; Rachael L Morton
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

10.  Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

Authors:  E Losina; M E Daigle; L G Suter; D J Hunter; D H Solomon; R P Walensky; J M Jordan; S A Burbine; A D Paltiel; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2013-02-04       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.